Tolerability of BRAF/MEK inhibitor combinations : adverse event evaluation and management

Heinzerling, Lucie; Eigentler, Thomas K.; Fluck, Michael; Hassel, Jessica C.; Heller-Schenck, Daniela; Leipe, Jan; Pauschinger, Matthias; Vogel, Arndt; Zimmer, Lisa; Gutzmer, Ralf

dc.contributor.author	Eigentler, Thomas
dc.date.accessioned	2020-07-28T14:08:13Z
dc.date.available	2020-07-28T14:08:13Z
dc.date.issued	2019
dc.identifier.issn	2059-7029
dc.identifier.uri	http://hdl.handle.net/10900/104151
dc.language.iso	en	de_DE
dc.publisher	Bmj Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1136/esmoopen-2019-000491	de_DE
dc.subject.ddc	610	de_DE
dc.title	Tolerability of BRAF/MEK inhibitor combinations : adverse event evaluation and management	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_01898
utue.personen.roh	Heinzerling, Lucie
utue.personen.roh	Eigentler, Thomas K.
utue.personen.roh	Fluck, Michael
utue.personen.roh	Hassel, Jessica C.
utue.personen.roh	Heller-Schenck, Daniela
utue.personen.roh	Leipe, Jan
utue.personen.roh	Pauschinger, Matthias
utue.personen.roh	Vogel, Arndt
utue.personen.roh	Zimmer, Lisa
utue.personen.roh	Gutzmer, Ralf
dcterms.isPartOf.ZSTitelID	Esmo Open	de_DE
dcterms.isPartOf.ZS-Issue	Article UNSP e000491	de_DE
dcterms.isPartOf.ZS-Volume	4	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE